Skip to content

Adapting and examining a psychoeducational approach to depression for general practice: a controlled study

Adapting and examining a psychoeducational approach to depression for general practice: a controlled study

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
DRKS
Registry ID
DRKS00030083
Enrollment
162
Registered
2022-12-22
Start date
2023-01-02
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F31.0 F31.1 F31.2 F31.3 F31.4 F31.5 F31.6 F31.7 F31.8 F31.9 F32.0 F32.1 F32.8 F32.9 F33.0 F33.1 F33.4 F33.8 F33.9 F34.0 F34.1 F34.8 F34.9 F38.0 F38.1 F38.8

Interventions

Group 1: Patients in the intervention group participate in a three-month psychoeducation programme (four sessions) within the respective general practitioner's practice, which is carried out by the ge
Post-measurement general practitioners: Feedback) determined. Three months after t1, a follow-up measurement (t2) is performed (BDI-II, PHQ-9, D-Lit-R, FERUS, PAM13-D, GAD-7, PHQ-15). Group 2: Patien

Sponsors

Institute of General Practice and Health Services Research, Klinikum rechts der Isar/Technische Universität München
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: - Present diagnosis of depressive disorder(s) (ICD-10: F31.X-F38.X) - and/or elevated depression score (BDI >14) - Age: 18-80 years - Consent to study participation: written and verbal

Exclusion criteria

Exclusion criteria: - Current outpatient psychotherapy - Previous disease(s), with severe cognitive impairment (e.g. dementia) - Presence of the following ICD-10 diagnoses: F32.3, F33.3, F20-29, F10-19 - very advanced severely progredient physical disease - insufficient mobility to visit the practice - insufficient ability to speak the German language

Design outcomes

Primary

MeasureTime frame
1. Examination of the efficacy of psychoeducation regarding depressive symptoms of the patients in the intervention group compared to the control group. Measure: Baseline-adjusted difference of the depression score in the BDI-II between intervention and control group 1) after psychoeducation/conventional treatment (within the month after completion of the 4th session or 12 weeks after study inclusion) = primary outcome, 2) 3 months after post-measurement (3-month follow-up). 2. Examination of the efficacy concerning patients' self-efficacy in the intervention group compared to the control group. Measure: Baseline-adjusted difference in total FE-RUS score between intervention and control group 1) after psychoeducation/conventional treatment (within the month after completion of the 4th session or 12 weeks after study inclusion) = primary outcome, 2) 3 months after post-measurement (3-month follow-up). 3. Examination of efficacy concerning the increase in depression literacy in comparison to the control group. Measure: Baseline-adjusted difference in total depression literacy questionnaire score (D-Lit-R) between intervention and control group 1) after psychoeducation/conventional treatment (within the month after completion of the 4th session or 12 weeks after study inclusion) = primary outcome, 2) 3 months after post-measurement (3-month follow-up). 4. Examination of the intervention's effect on patient activation. Measure: Baseline-adjusted difference in total score on the PAM- 13 between intervention and control group 1) after psychoeducation/conventional treatment (within the month after completion of the 4th session or 12 weeks after study inclusion) = primary outcome, 2) 3 months after post-measurement (3-month follow-up).

Secondary

MeasureTime frame
1. Evaluation of the feasibility of the psychoeducation programme for the general practitioners. 2. Examination of the individual benefit of the programme for the general practitioners. Aims 1 and 2 will be assessed using the general practitioners' feedback questionnaire. 3. Examination of the individual benefit of the programme for the patients. Assessment based on the patients' feedback questionnaire. 4. Exploratory examination of the attitudes of participating general practitioners towards patients with depression. Analysis of the descriptive statistics of the R-DAQ questionnaire.

Countries

Germany

Contacts

Public ContactFeyza Gökce

Institute of General Practice and Health Services Research, Klinikum rechts der Isar/Technische Universität München

feyza.goekce@mri.tum.de+49-89-6146589-14

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026